Species Distribution and Antifungal Susceptibility of Invasive Candidiasis: A 2016-2017 Multicenter Surveillance Study in Beijing, China

References

• Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373(15):1445–1456. doi:10.1056/NEJMra131539926444731
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Patterson TF. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216(suppl_3):S445–S451. doi:10.1093/infdis/jix13128911043
   PubMed Web of Science ®Google Scholar
• Liu WL, Lai CC, Li MC, et al. Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007–2014. J Microbiol Immunol Infect. 2019;52(4):612–619. doi:10.1016/j.jmii.2017.08.00728886952
   PubMedGoogle Scholar
• Horn David L, Neofytos D, Anaissie Elias J, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48(12):1695–1703. doi:10.1086/59903919441981
   PubMed Web of Science ®Google Scholar
• Lamoth F, Lockhart SR, Berkow EL, Calandra T. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother. 2018;73(suppl_1):i4–i13. doi:10.1093/jac/dkx44429304207
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty Years of the SENTRY Antifungal Surveillance Program: results for Candida Species From 1997–2016. Open Forum Infect Dis. 2019;6(Suppl 1):S79–S94. doi:10.1093/ofid/ofy35830895218
   PubMed Web of Science ®Google Scholar
• Tseng TY, Chen TC, Ho CM, et al. Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: an experience in a tertiary hospital in mid-Taiwan. J Microbiol Immunol Infect. 2018;51(4):552–558. doi:10.1016/j.jmii.2016.08.01528625801
   PubMedGoogle Scholar
• Fan X, Xiao M, Liao K, et al. Notable increasing trend in azole non-susceptible candida tropicalis causing invasive candidiasis in China (August 2009 to July 2014): molecular epidemiology and clinical azole consumption. Front Microbiol. 2017;8:464. doi:10.3389/fmicb.2017.0046428382028
   PubMed Web of Science ®Google Scholar
• Xiao M, Sun ZY, Kang M, et al. Five-Year National Surveillance of Invasive Candidiasis: species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study. J Clin Microbiol. 2018;56(7):JCM.00577–00518. doi:10.1128/JCM.00577-18
   Web of Science ®Google Scholar
• Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64(2):134–140. doi:10.1093/cid/ciw69127988485
   PubMed Web of Science ®Google Scholar
• Guo LN, Xiao M, Cao B, et al. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China. Future Microbiol. 2017;12(12):1075–1086. doi:10.2217/fmb-2017-003628836465
   PubMed Web of Science ®Google Scholar
• Zhang L, Xiao M, Wang H, et al. Yeast identification algorithm based on use of the Vitek MS system selectively supplemented with ribosomal DNA sequencing: proposal of a reference assay for invasive fungal surveillance programs in China. J Clin Microbiol. 2014;52(2):572–577. doi:10.1128/JCM.02543-1324478490
   PubMed Web of Science ®Google Scholar
• Wang H, Li Y, Fan X, Chiueh TS, Xu YC, Hsueh PR. Evaluation of bruker biotyper and vitek MS for the identification of Candida tropicalis on different solid culture media. J Microbiol Immunol Infect. 2019;52(4):604–611. doi:10.1016/j.jmii.2017.11.00229191475
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard 3rd Ed. CLSI Document M27-A3. Wayne, PA: Humana Press; 2008.
   Google Scholar
• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Fourth Informational Supplement M27-S4. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antifungal Susceptibility Testing of Yeasts. 1st Ed. CLSI Document M60. Wayne, PA; 2017.
   Google Scholar
• McCarty TP, Pappas PG. Invasive Candidiasis. Infect Dis Clin North Am. 2016;30(1):103–124. doi:10.1016/j.idc.2015.10.01326739610
   PubMed Web of Science ®Google Scholar
• Lin GL, Chang HH, Lu CY, et al. Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan. J Microbiol Immunol Infect. 2018;51(2):251–259. doi:10.1016/j.jmii.2016.08.01128089099
   PubMedGoogle Scholar
• Lortholary O, Renaudat C, Sitbon K, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010). Intensive Care Med. 2014;40(9):1303–1312. doi:10.1007/s00134-014-3408-325097069
   PubMed Web of Science ®Google Scholar
• Webb BJ, Ferraro JP, Rea S, Kaufusi S, Goodman BE, Spalding J. Epidemiology and clinical features of invasive fungal infection in a US health care network. Open Forum Infect Dis. 2018;5(8):ofy187. doi:10.1093/ofid/ofy18730151412
   PubMed Web of Science ®Google Scholar
• Hesstvedt L, Gaustad P, Andersen CT, et al. Twenty-two years of candidaemia surveillance: results from a Norwegian national study. Clin Microbiol Infect. 2015;21(10):938–945. doi:10.1016/j.cmi.2015.06.00826093076
   PubMed Web of Science ®Google Scholar
• Tan TY, Hsu LY, Alejandria MM, et al. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region. Med Mycol. 2016;54(5):471–477. doi:10.1093/mmy/myv11426868904
   PubMed Web of Science ®Google Scholar
• Farooqi JQ, Jabeen K, Saeed N, et al. Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility. J Med Microbiol. 2013;62(Pt 2):259–268. doi:10.1099/jmm.0.048785-023105021
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Dzajic E, Jensen RH, et al. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect. 2013;19(8):E343–E353. doi:10.1111/1469-0691.1221223607326
   PubMed Web of Science ®Google Scholar
• Schuster MG, Meibohm A, Lloyd L, Strom B. Risk factors and outcomes of Candida krusei bloodstream infection: a matched, case-control study. J Infect. 2013;66(3):278–284. doi:10.1016/j.jinf.2012.11.00223174708
   PubMed Web of Science ®Google Scholar
• Khan Z, Ahmad S, Al-Sweih N, Khan S, Joseph L. Candida lusitaniae in Kuwait: prevalence, antifungal susceptibility and role in neonatal fungemia. PLoS One. 2019;14(3):e0213532. doi:10.1371/journal.pone.021353230845213
   PubMed Web of Science ®Google Scholar
• Minari A, Hachem R, Raad I. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin Infect Dis. 2001;32(2):186–190. doi:10.1086/31847311170906
   PubMed Web of Science ®Google Scholar
• Jung DS, Farmakiotis D, Jiang Y, Tarrand JJ, Kontoyiannis DP. Uncommon Candida species fungemia among cancer patients, Houston, Texas, USA. Emerg Infect Dis. 2015;21(11):1942–1950. doi:10.3201/eid2111.15040426488845
   PubMed Web of Science ®Google Scholar
• Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2018;31(1).
   PubMed Web of Science ®Google Scholar
• Trouve C, Blot S, Hayette MP, et al. Epidemiology and reporting of candidaemia in Belgium: a multi-centre study. Eur J Clin Microbiol Infect Dis. 2017;36(4):649–655. doi:10.1007/s10096-016-2841-327858242
   PubMed Web of Science ®Google Scholar
• Shah DN, Yau R, Lasco TM, et al. Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia. Antimicrob Agents Chemother. 2012;56(6):3239–3243. doi:10.1128/AAC.00019-1222411611
   PubMed Web of Science ®Google Scholar
• Cornely OA, Bassetti M, Calandra T, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(Suppl 7):19–37. doi:10.1111/1469-0691.1203923137135
   PubMed Web of Science ®Google Scholar
• Alexander BD, Johnson MD, Pfeiffer CD, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013;56(12):1724–1732. doi:10.1093/cid/cit13623487382
   PubMed Web of Science ®Google Scholar
• Chindamporn A, Chakrabarti A, Li R, et al. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia Fungal Working Group (AFWG) initiative. Med Mycol. 2018;56(4):416–425. doi:10.1093/mmy/myx06629036605
   PubMed Web of Science ®Google Scholar